Vosoritide Injection

DRUG2 trials

Sponsors

BioMarin Pharmaceutical

Conditions

Idiopathic Short StatureNoonan Syndrome

Phase 2

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

RecruitingNCT06382155

BioMarin PharmaceuticalIdiopathic Short Stature

Start: 2024-10-21End: 2036-12-01Target: 100Updated: 2026-05-22

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

RecruitingNCT06668805

BioMarin PharmaceuticalNoonan Syndrome

Start: 2024-11-22End: 2041-09-01Target: 30Updated: 2026-05-11